Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A cluster randomized trial of primary care patients with overweight or obesity found that those using an online program with added support lost significantly more weight (6.8 lbs on average) at 12 months compared to those using only an online program (4.2 lbs) or receiving usual care (2.6 lbs)
GLP-1 medications may increase the risk of gallbladder problems, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis)
Trial SURPASS-1 (Lancet 2021) Population 478 adults with T2D, monotherapy vs placebo
Rapid muscle loss during Retatrutide treatment can compromise functional capacity, especially in older adults
A clinical trial by Meissner and colleagues with the GLP-1 lixisenatide demonstrated a modest reduction in motor disability progression in patients with early-stage PD
US$ 24.66
US$ 23.10
US$ 20.88
